Product Details
Zofran ODT (Tablet)
Ondansetron Hydrochloride8 mg
DIN/PIN/NPN
02239373
Manufacturer
Sandoz Canada Inc.
Formulary Listing Date
2000-04-17
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Not a Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
A04AA01
Interchangeable Products
DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
---|---|---|---|
02239373 | Zofran ODT (Tablet) | NA | NA |
02389991 | Ondissolve ODF (Film) | 4.9930 | 3.8840 |
02481731 | Ondansetron ODT (Tablet) | 4.9930 | 3.8840 |
02487349 | Mint-Ondansetron ODT (Tablet) | 4.9930 | 3.8840 |
02511290 | Auro-Ondansetron ODT (Tablet) | 4.9930 | 3.8840 |
02514974 | Mar-Ondansetron ODT Tablet | 4.9930 | 3.8840 |
02519240 | Ondansetron ODT (Tablet) | 4.9930 | 3.8840 |
02519453 | PMS-Ondansetron ODT Tablet | 4.9930 | 3.8840 |
02524287 | Ondansetron ODT (Tablet) | 4.9930 | 3.8840 |
02535327 | Accel-Ondansetron ODT (Tablet) | 3.8840 | 3.8840 |
02541378 | Jamp Ondansetron ODF | 4.9930 | 3.8840 |
LU Clinical Criteria
NOEAP Criteria
Therapeutic Class | Reimbursement Criteria |
---|---|
Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |